Abstract：
Background: While telemedicine may increase health care access for vulnerable populations, data are limited on whether people with opioid use disorder (PWOUD) are satisfied with telemedicine. We assessed PWOUD satisfaction with telemedicine and identified factors that increase telemedicine satisfaction. Methods: We conducted a mixed-methods study among hepatitis C virus (HCV)-infected persons enrolled at 12 opioid treatment programs (OTPs) throughout New York State. Participants successfully completed HCV treatment either through telemedicine integrated into OTPs (N = 238) or through offsite referral (N = 106). We evaluated Patient Satisfaction Questionnaire (PSQ) response scores at the initial and final health care encounters and subsequently interviewed telemedicine study participants (N = 25) to assess their experiences with telemedicine. Results: All participants (N = 344) successfully completed HCV treatment. We observed no differences in PSQ scores between telemedicine and in-person encounters (98.3% and 98.7% of telemedicine participants provided PSQ scores of satisfied or highly satisfied at each timepoint, respectively). Study participants indicated that attributes associated with high telemedicine encounter satisfaction included: (1) communicating study information, (2) gaining trust, and (3) delivering patient-centered care. Participants weighted \"General Satisfaction\" and \"Time Spent with Doctor\" higher than \"Accessibility and Convenience,\" and female participants were significantly more satisfied than males. Satisfaction with health care delivery among all participants increased significantly comparing timepoints. Conclusions: Participants were highly satisfied with HCV telemedicine encounters equivalent to in-person encounters. Communication augments trust facilitating delivery of patient-centered care through telemedicine. Participants value empathy and trust with providers over accessibility and convenience. In summary, PWOUD are highly satisfied with the facilitated telemedicine model and value empathetic and trusting providers. ClinicalTrials.gov Identifier: NCT02933970.
摘要：
背景：虽然远程医疗可能会增加弱势群体的医疗保健服务，阿片类药物使用障碍(PWOUD)患者对远程医疗是否满意的数据有限.我们评估了PWOUD对远程医疗的满意度，并确定了提高远程医疗满意度的因素。方法：我们在纽约州参加12个阿片类药物治疗计划（OTP）的丙型肝炎病毒（HCV）感染者中进行了混合方法研究。参与者通过整合到OTP中的远程医疗（N=238）或通过异地转诊（N=106）成功完成了HCV治疗。我们在最初和最终的医疗保健会议上评估了患者满意度问卷（PSQ）的反应得分，随后采访了远程医疗研究参与者（N=25），以评估他们的远程医疗经验。结果：所有参与者（N=344）成功完成HCV治疗。我们观察到远程医疗和面对面接触之间的PSQ得分没有差异(98.3%和98.7%的远程医疗参与者在每个时间点提供满意或高度满意的PSQ得分,分别)。研究参与者指出，与远程医疗体验满意度高相关的属性包括：（1）传达研究信息，（2）获得信任，（3）提供以患者为中心的护理。参与者加权“总体满意度”和“与医生在一起的时间”高于“可访问性和便利性，“女性参与者的满意度明显高于男性。与时间点相比，所有参与者对医疗保健服务的满意度显着提高。结论：参与者对HCV远程医疗遭遇非常满意，相当于面对面的遭遇。沟通增加了信任，促进了通过远程医疗提供以患者为中心的护理。参与者重视对提供者的同理心和信任，而不是可访问性和便利性。总之,PWOUD对便利的远程医疗模型非常满意，并重视同情和信任的提供商。ClinicalTrials.gov标识符：NCT02933970。
